This document discusses two methods of gene silencing: RNA interference (RNAi) and antisense therapy. RNAi involves long double-stranded RNA being cut into small interfering RNAs (siRNAs) that bind to messenger RNA and prevent translation. Antisense therapy uses short antisense DNA oligonucleotides that are complementary to mRNA and form DNA-RNA hybrids that are degraded by RNaseH, blocking translation. Both methods allow targeted inhibition of gene expression for research and potential therapeutic applications.